Insulet Executive and Leadership Team

Ashley McEvoy, the President, Chief Executive Officer & Director at Insulet, directs the company's overarching strategy and operational execution. McEvoy guides Insulet's mission to innovate insulin delivery, focusing on expanding the reach and impact of the Omnipod platform for individuals with diabetes. This leadership role involves setting the strategic vision for product development, market expansion, and financial performance, ensuring alignment with the company's commitment to improving patient lives. Overseeing all corporate functions, McEvoy drives initiatives that enhance Insulet's market position and foster a culture of continuous improvement. The Chief Executive Officer ensures the company's long-term sustainability and growth by championing technological advancements and strategic partnerships. Ashley McEvoy's leadership is central to advancing Insulet's position as a pioneer in wearable diabetes technology and exploring new therapeutic applications for its drug delivery platform.

Flavia Pease, the Chief Financial Officer at Insulet, manages the company's financial operations and strategic fiscal planning. Pease oversees all aspects of financial reporting, budgeting, forecasting, and capital allocation, ensuring robust financial health and supporting Insulet's growth objectives. This critical role involves managing investor relations and communicating financial performance to stakeholders, reinforcing confidence in the company's trajectory. The Chief Financial Officer's responsibilities extend to optimizing financial strategies to support the development and commercialization of Insulet's innovative Omnipod product platform. By driving financial discipline and strategic investment, Pease ensures resources are effectively deployed to advance the company's mission of simplifying diabetes management. Flavia Pease's financial acumen is essential for navigating the complex economic landscape and securing the resources needed for Insulet's continued innovation and market leadership.

Ana Chadwick, the Executive Vice President & Chief Financial Officer & Treasurer at Insulet, directs comprehensive financial strategy and treasury operations. Chadwick oversees capital management, financial risk mitigation, and the execution of fiscal policies that underpin Insulet's operational and strategic goals. This executive position involves managing the company's liquidity, debt, and equity financing, ensuring optimal capital structure to support innovation and expansion of the Omnipod platform. The Chief Financial Officer & Treasurer's purview includes safeguarding company assets and driving financial efficiency across all departments. By managing the company's financial resources and relationships with financial institutions, Chadwick ensures Insulet maintains a strong financial foundation. Ana Chadwick's leadership in financial stewardship is vital for sustaining Insulet's commitment to advancing medical device technology and improving patient outcomes globally.

Timothy Stonesifer, the Chief Financial Officer, At Alcon Inc at Insulet, provides strategic financial leadership and oversight. Stonesifer directs financial planning, analysis, and reporting, ensuring fiscal integrity and supporting the company's growth initiatives. This executive role involves managing financial resources to drive innovation in medical device technology and expand market reach for products like the Omnipod system. The Chief Financial Officer's responsibilities include optimizing financial performance, managing risk, and ensuring compliance with regulatory standards. By guiding financial strategy, Stonesifer contributes to the long-term stability and success of the organization. Timothy Stonesifer's financial expertise is instrumental in shaping Insulet's fiscal direction and supporting its mission to improve patient lives through advanced medical solutions.

Rakesh Pant, the Staff Software Engineer & Chief Technology Officer, Cloud Data Products at Insulet, spearheads the technological vision and development for cloud-based data solutions. Pant leads the engineering teams responsible for architecting, building, and deploying robust cloud infrastructure that supports Insulet's data-driven product strategies, particularly for the Omnipod platform. This role involves defining the technical roadmap for data products, ensuring scalability, security, and performance of cloud services. The Chief Technology Officer, Cloud Data Products, drives innovation in data analytics and management, enabling deeper insights into product usage and patient outcomes. By fostering a culture of technical excellence, Pant ensures Insulet leverages cutting-edge cloud technologies to enhance its offerings and operational efficiency. Rakesh Pant's expertise is crucial for advancing Insulet's digital capabilities and solidifying its leadership in connected medical devices.

Nikkole DeMars, the Director, E2E CX Planning and Operations (Chief of Staff To GVP of E2E CX) at Insulet, orchestrates end-to-end customer experience initiatives and operational planning. DeMars focuses on enhancing the customer journey across all touchpoints, ensuring seamless integration of services and support for users of the Omnipod platform. This role involves strategic planning and operational execution to optimize customer satisfaction and loyalty. The Director, E2E CX Planning and Operations collaborates closely with cross-functional teams to align customer experience strategies with business objectives. By driving operational efficiency and process improvements, DeMars ensures Insulet delivers exceptional service and support. Nikkole DeMars's dedication to customer-centric operations is vital for reinforcing Insulet's commitment to simplifying life for individuals managing chronic conditions.

Trang Ly, the Senior Vice President, Chief Medical Officer at Insulet, provides critical medical and scientific leadership for the company's product development and strategic initiatives. Ly oversees clinical research, regulatory affairs, and medical affairs, ensuring Insulet's innovations, including the Omnipod Insulin Management System, meet the highest standards of safety and efficacy. This executive position involves guiding clinical trial design, interpreting medical data, and advising on the clinical implications of new technologies. The Chief Medical Officer plays a key role in shaping the company's medical strategy and fostering relationships with the medical community. By ensuring robust clinical evidence and adherence to medical best practices, Ly supports Insulet's mission to improve patient outcomes. Trang Ly's medical expertise is fundamental to advancing Insulet's position as a leader in diabetes care and exploring new therapeutic applications.